2026-2031 Global Microbiome Therapeutics Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

August 2026 | 150 pages | ID: M3776A26FB7BEN
HNY RESEARCH

US$ 3,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
HNY Research projects that the Microbiome Therapeutics market size will grow from 575.38 Million USD in 2025 to 3397.91 Million USD by 2031, at an estimated CAGR of 34.44%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.

For 2025 regional market size, the North America market size was 138.9 Million USD, the Europe market size was 99.77 Million USD, and the Asia market size was 106.56 Million USD.

This report presents a detailed and holistic analysis of the global Microbiome Therapeutics market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.

All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.

Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Microbiome Therapeutics manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Finch Therapeutics
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
Ferring
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Vedanta Biosciences
Metabogen

By Type
Upper GIT
Lower GIT

By Application
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
  • The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
  • The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
  • The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
  • Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
  • The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
  • To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
  • Assess the production processes, major issues, and solutions to mitigate the development risk.
  • To understand the most affecting driving and restraining forces in the market and its impact in the global market.
  • Learn about the market strategies that are being adopted by leading respective organizations.
  • To understand the future outlook and prospects for the market.
  • Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Global Market Size by Player 2020-2025
1.4 Global Market Size by Type in 2026-2031
  1.4.1 Global Market Size by Type in 2026-2031
  1.4.2 Upper GIT
  1.4.3 Lower GIT
1.5 Global Market Size by Application in 2026-2031
  1.5.1 Global Market Size by Application in 2026-2031
  1.5.2 C. difficile Infection (CDI)
  1.5.3 Inflammatory Bowel Disease (IBD)
  1.5.4 Orphan Drug
  1.5.5 Immuno-oncology
  1.5.6 Others
1.6 Global Market Size by Region 2026-2031
  1.6.1 Global Market Size Outlook 2026-2031
  1.6.2 North America
  1.6.3 East Asia
  1.6.4 Europe
  1.6.5 South Asia
  1.6.6 Southeast Asia
  1.6.7 Middle East
  1.6.8 Africa
  1.6.9 Oceania
  1.6.10 South America
  1.6.11 Rest of the World

2 MANUFACTURING COST STRUCTURE ANALYSIS 2026

2.1 Manufacturing Cost Structure Analysis of Microbiome Therapeutics 2026
2.2 Industry Chain Structure Analysis of Microbiome Therapeutics 2026

3 MARKET COMPETITION ANALYSIS BY PLAYERS 2020-2025

3.1 Global Microbiome Therapeutics Production Capacity by Players 2020-2025
3.2 Global Microbiome Therapeutics Production Revenue by Players 2020-2025
3.3 Global Microbiome Therapeutics Ex-Factory Price by Players 2020-2025

4 MARKET COMPETITION ANALYSIS BY REGION 2020-2025

4.1 Global Microbiome Therapeutics Production by Region 2020-2025
  4.1.1 Global Microbiome Therapeutics Production Volume by Region 2020-2025
  4.1.2 Global Microbiome Therapeutics Production Revenue by Region 2020-2025
4.2 Global Microbiome Therapeutics Consumption Volume by Region 2020-2025
4.3 North America Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.3.1 North America Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.3.2 North America Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.3.3 North America Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.3.4 North America Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.4 East Asia Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.4.1 East Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.4.2 East Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.4.3 East Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.4.4 East Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.5 Europe Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.5.1 Europe Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.5.2 Europe Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.5.3 Europe Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.5.4 Europe Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.6 South Asia Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.6.1 South Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.6.2 South Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.6.3 South Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.6.4 South Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.7 Southeast Asia Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.7.1 Southeast Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.7.2 Southeast Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.7.3 Southeast Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.7.4 Southeast Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.8 Middle East Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.8.1 Middle East Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.8.2 Middle East Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.8.3 Middle East Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.8.4 Middle East Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.9 Africa Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.9.1 Africa Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.9.2 Africa Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.9.3 Africa Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.9.4 Africa Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.10 Oceania Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.10.1 Oceania Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.10.2 Oceania Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.10.3 Oceania Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.10.4 Oceania Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
4.11 South America Microbiome Therapeutics Market Competition Analysis 2020-2025
  4.11.1 South America Microbiome Therapeutics Production Volume Analysis 2020-2025
  4.11.2 South America Microbiome Therapeutics Production Revenue Analysis 2020-2025
  4.11.3 South America Microbiome Therapeutics Sales Volume by Key Players 2020-2025
  4.11.4 South America Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025

5 MARKET COMPETITION ANALYSIS BY TYPE (SALES VIEW) 2020-2031

5.1 Global Microbiome Therapeutics Historic Market Size by Type in 2020-2025
5.2 Global Microbiome Therapeutics Forecasted Market Size by Type in 2026-2031

6 MARKET COMPETITION ANALYSIS BY APPLICATION (CONSUMPTION VIEW) 2020-2031

6.1 Global Microbiome Therapeutics Historic Market Size by Application in 2020-2025
6.2 Global Microbiome Therapeutics Forecasted Market Size by Application in 2026-2031

7 LEADING COMPANY PROFILES AND KEY FIGURES IN MICROBIOME THERAPEUTICS BUSINESS 2020-2025

7.1 Seres Therapeutics
  7.1.1 Seres Therapeutics Company Profile
  7.1.2 Seres Therapeutics Microbiome Therapeutics Product Specification
  7.1.3 Seres Therapeutics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.2 Assembly Biosciences
  7.2.1 Assembly Biosciences Company Profile
  7.2.2 Assembly Biosciences Microbiome Therapeutics Product Specification
  7.2.3 Assembly Biosciences Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.3 Synthetic Biologics
  7.3.1 Synthetic Biologics Company Profile
  7.3.2 Synthetic Biologics Microbiome Therapeutics Product Specification
  7.3.3 Synthetic Biologics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.4 Finch Therapeutics
  7.4.1 Finch Therapeutics Company Profile
  7.4.2 Finch Therapeutics Microbiome Therapeutics Product Specification
  7.4.3 Finch Therapeutics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.5 PureTech
  7.5.1 PureTech Company Profile
  7.5.2 PureTech Microbiome Therapeutics Product Specification
  7.5.3 PureTech Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.6 Synlogic
  7.6.1 Synlogic Company Profile
  7.6.2 Synlogic Microbiome Therapeutics Product Specification
  7.6.3 Synlogic Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.7 Enterome BioScience
  7.7.1 Enterome BioScience Company Profile
  7.7.2 Enterome BioScience Microbiome Therapeutics Product Specification
  7.7.3 Enterome BioScience Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.8 4D Pharma
  7.8.1 4D Pharma Company Profile
  7.8.2 4D Pharma Microbiome Therapeutics Product Specification
  7.8.3 4D Pharma Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.9 Second Genome
  7.9.1 Second Genome Company Profile
  7.9.2 Second Genome Microbiome Therapeutics Product Specification
  7.9.3 Second Genome Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.10 Ferring
  7.10.1 Ferring Company Profile
  7.10.2 Ferring Microbiome Therapeutics Product Specification
  7.10.3 Ferring Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.11 C3 Jian
  7.11.1 C3 Jian Company Profile
  7.11.2 C3 Jian Microbiome Therapeutics Product Specification
  7.11.3 C3 Jian Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.12 Rebiotix
  7.12.1 Rebiotix Company Profile
  7.12.2 Rebiotix Microbiome Therapeutics Product Specification
  7.12.3 Rebiotix Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.13 MicroBiome Therapeutics LLC
  7.13.1 MicroBiome Therapeutics LLC Company Profile
  7.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Specification
  7.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.14 Metabiomics
  7.14.1 Metabiomics Company Profile
  7.14.2 Metabiomics Microbiome Therapeutics Product Specification
  7.14.3 Metabiomics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.15 Ritter Pharmaceuticals
  7.15.1 Ritter Pharmaceuticals Company Profile
  7.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Specification
  7.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.16 Symberix
  7.16.1 Symberix Company Profile
  7.16.2 Symberix Microbiome Therapeutics Product Specification
  7.16.3 Symberix Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.17 OpenBiome
  7.17.1 OpenBiome Company Profile
  7.17.2 OpenBiome Microbiome Therapeutics Product Specification
  7.17.3 OpenBiome Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.18 Azitra
  7.18.1 Azitra Company Profile
  7.18.2 Azitra Microbiome Therapeutics Product Specification
  7.18.3 Azitra Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.19 Symbiotix Biotherapies
  7.19.1 Symbiotix Biotherapies Company Profile
  7.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Specification
  7.19.3 Symbiotix Biotherapies Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.20 Vedanta Biosciences
  7.20.1 Vedanta Biosciences Company Profile
  7.20.2 Vedanta Biosciences Microbiome Therapeutics Product Specification
  7.20.3 Vedanta Biosciences Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.21 Metabogen
  7.21.1 Metabogen Company Profile
  7.21.2 Metabogen Microbiome Therapeutics Product Specification
  7.21.3 Metabogen Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025

8 MARKET FORECAST ANALYSIS ON PRODUCTION AND SUPPLY BY REGION 2026-2031

8.1 Global Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
8.2 Global Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
8.3 Global Forecasted Production Volume of Microbiome Therapeutics by Region 2026-2031
  8.3.1 North America Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.2 East Asia Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.3 Europe Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.4 South Asia Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.5 Southeast Asia Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.6 Middle East Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.7 Africa Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.8 Oceania Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.9 South America Forecasted Production of Microbiome Therapeutics 2026-2031
  8.3.10 Rest of the World Forecasted Production of Microbiome Therapeutics 2026-2031
8.4 Global Forecasted Sales by Type and Consumption by Application in 2026-2031
  8.4.1 Global Forecasted Sales Volume, Sales Revenue and Sales Price by Type in 2026-2031
  8.4.2 Global Forecasted Consumption Volume and Consumption Value by Application in 2026-2031

9 MARKET FORECAST ANALYSIS ON CONSUMPTION AND DEMAND BY REGION 2026-2031

9.1 North America Forecasted Consumption of Microbiome Therapeutics by Country
9.2 East Asia Forecasted Consumption of Microbiome Therapeutics by Country
9.3 Europe Market Forecasted Consumption of Microbiome Therapeutics by Country
9.4 South Asia Forecasted Consumption of Microbiome Therapeutics by Country
9.5 Southeast Asia Forecasted Consumption of Microbiome Therapeutics by Country
9.6 Middle East Forecasted Consumption of Microbiome Therapeutics by Country
9.7 Africa Forecasted Consumption of Microbiome Therapeutics by Country
9.8 Oceania Forecasted Consumption of Microbiome Therapeutics by Country
9.9 South America Forecasted Consumption of Microbiome Therapeutics by Country
9.10 Rest of the World Forecasted Consumption of Microbiome Therapeutics by Country

10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS ANALYSIS

10.1 Marketing Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels

11 MARKET DYNAMICS ANALYSIS

11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis

12 CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Who Trust HNY Research
13.4 Disclaimer
Research Methodology

LIST OF TABLES

Table Global Market Size in Production Revenue by Player 2020-2025
Table Global Market Size in Sales Revenue by Type in 2026-2031
Table Global Market Size in Consumption Value by Application in 2026-2031
Table Global Microbiome Therapeutics Production Capacity by Players 2020-2025
Table Global Microbiome Therapeutics Production Volume by Players 2020-2025
Table Global Microbiome Therapeutics Production Volume Market Share by Players 2020-2025
Table Global Microbiome Therapeutics Production Revenue by Players 2020-2025
Table Global Microbiome Therapeutics Production Revenue Share by Players 2020-2025
Table Global Microbiome Therapeutics Ex-Factory Price of Key Players 2020-2025
Table Global Microbiome Therapeutics Production Volume by Region 2020-2025
Table Global Microbiome Therapeutics Production Volume Market Share by Region 2020-2025
Table Global Microbiome Therapeutics Production Revenue by Region 2020-2025
Table Global Microbiome Therapeutics Production Revenue Market Share by Region 2020-2025
Table Global Microbiome Therapeutics Consumption Volume by Region 2020-2025
Table Global Microbiome Therapeutics Consumption Volume Market Share by Region 2020-2025
Table North America Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table North America Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table East Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table East Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Europe Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table Europe Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table South Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table South Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Southeast Asia Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table Southeast Asia Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Middle East Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table Middle East Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Africa Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table Africa Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Oceania Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table Oceania Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table South America Microbiome Therapeutics Sales Volume by Key Players 2020-2025
Table South America Microbiome Therapeutics Production, Consumption, Import and Export 2020-2025
Table Global Microbiome Therapeutics Historic Sales Revenue by Type in 2020-2025
Table Global Microbiome Therapeutics Historic Sales Revenue Market Share by Type in 2020-2025
Table Global Microbiome Therapeutics Forecasted Sales Revenue by Type in 2026-2031
Table Global Microbiome Therapeutics Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Microbiome Therapeutics Historic Consumption Value by Application in 2020-2025
Table Global Microbiome Therapeutics Historic Cosumption Value Market Share by Application in 2020-2025
Table Global Microbiome Therapeutics Forecasted Cononumption Value by Application in 2026-2031
Table Global Microbiome Therapeutics Forecasted Cononumption Value Market Share by Application in 2026-2031
Table Seres Therapeutics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Assembly Biosciences Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Synthetic Biologics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Finch Therapeutics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table PureTech Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Synlogic Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Enterome BioScience Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table 4D Pharma Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Second Genome Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Ferring Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table C3 Jian Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Rebiotix Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Metabiomics Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Ritter Pharmaceuticals Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Symberix Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table OpenBiome Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Azitra Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Symbiotix Biotherapies Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Vedanta Biosciences Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Metabogen Microbiome Therapeutics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Global Forecasted Production Volume of Microbiome Therapeutics by Region 2026-2031
Table Global Forecasted Sales Volume by Type in 2026-2031
Table Global Forecasted Sales Volume Market Share by Type in 2026-2031
Table Global Forecasted Sales Revenue by Type in 2026-2031
Table Global Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Forecasted Sales Price by Type in 2026-2031
Table Global Forecasted Consumption Volume by Application in 2026-2031
Table Global Forecasted Consumption Value by Application in 2026-2031
Table Market Key Trends
Table Key Opportunities and Drivers: Impact Analysis 2026-2031
Table Key Challenges
Table Research Programs/Design for This Report
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

LIST OF FIGURES

Figure Global Market Share in Sales Revenue by Type in 2025
Figure Upper GIT Features
Figure Lower GIT Features
Figure Global Market Share in Consumption Value by Application in 2025
Figure C. difficile Infection (CDI) Case Studies
Figure Inflammatory Bowel Disease (IBD) Case Studies
Figure Orphan Drug Case Studies
Figure Immuno-oncology Case Studies
Figure Others Case Studies
Figure Global Market Size in Sales Revenue Outlook 2026-2031
Figure North America Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure East Asia Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Europe Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure South Asia Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure South America Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Middle East Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Africa Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Oceania Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure South America Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Rest of the World Microbiome Therapeutics Sales Revenue and Growth Rate 2026-2031
Figure Manufacturing Cost Structure Analysis of Microbiome Therapeutics 2026
Figure Industry Chain Structure Analysis of Microbiome Therapeutics 2026
Figure Global Microbiome Therapeutics Production Volume Market Share by Region in 2025
Figure Global Microbiome Therapeutics Production Revenue Market Share by Region in 2025
Figure North America Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure North America Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure East Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure East Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Europe Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure Europe Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure South Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure South Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Southeast Asia Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure Southeast Asia Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Middle East Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure Middle East Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Africa Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure Africa Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Oceania Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure Oceania Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure South America Microbiome Therapeutics Production Volume Analysis 2020-2025
Figure South America Microbiome Therapeutics Production Revenue Analysis 2020-2025
Figure Seres Therapeutics Microbiome Therapeutics Product Specification
Figure Assembly Biosciences Microbiome Therapeutics Product Specification
Figure Synthetic Biologics Microbiome Therapeutics Product Specification
Figure Finch Therapeutics Microbiome Therapeutics Product Specification
Figure PureTech Microbiome Therapeutics Product Specification
Figure Synlogic Microbiome Therapeutics Product Specification
Figure Enterome BioScience Microbiome Therapeutics Product Specification
Figure 4D Pharma Microbiome Therapeutics Product Specification
Figure Second Genome Microbiome Therapeutics Product Specification
Figure Ferring Microbiome Therapeutics Product Specification
Figure C3 Jian Microbiome Therapeutics Product Specification
Figure Rebiotix Microbiome Therapeutics Product Specification
Figure MicroBiome Therapeutics LLC Microbiome Therapeutics Product Specification
Figure Metabiomics Microbiome Therapeutics Product Specification
Figure Ritter Pharmaceuticals Microbiome Therapeutics Product Specification
Figure Symberix Microbiome Therapeutics Product Specification
Figure OpenBiome Microbiome Therapeutics Product Specification
Figure Azitra Microbiome Therapeutics Product Specification
Figure Symbiotix Biotherapies Microbiome Therapeutics Product Specification
Figure Vedanta Biosciences Microbiome Therapeutics Product Specification
Figure Metabogen Microbiome Therapeutics Product Specification
Figure Global Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Global Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure North America Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure North America Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure East Asia Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure East Asia Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Europe Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Europe Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure South Asia Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure South Asia Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Southeast Asia Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Southeast Asia Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Middle East Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Middle East Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Africa Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Africa Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Oceania Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Oceania Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure South America Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure South America Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure Rest of the World Forecasted Production Capacity of Microbiome Therapeutics 2026-2031
Figure Rest of the World Forecasted Production Revenue of Microbiome Therapeutics 2026-2031
Figure North America Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure North America Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure East Asia Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure East Asia Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Europe Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Europe Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure South Asia Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure South Asia Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Southeast Asia Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Southeast Asia Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Middle East Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Middle East Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Africa Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Africa Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Oceania Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Oceania Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure South America Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure South America Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Rest of the World Forecasted Consumption of Microbiome Therapeutics 2026-2031
Figure Rest of the World Forecasted Consumption of Microbiome Therapeutics 2031 by Country
Figure Channels of Distribution
Figure Porter's Five Forces Analysis
Figure Key Executives Interviewed


More Publications